A recent study indicates that in prostate cancer, the microRNA miR-106a-5p promotes cell proliferation by inhibiting Rbm24 expression, and overexpression of wild-type Rbm24 is able to inhibit tumorigenesis [41]. Here, RBM24 is linked to prostate cancer.